RPL32P33

Across TCGA pan-cancer cohorts, RPL32P33 RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RPL32P33 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL32P33 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL32P33 expression acts as an unfavorable survival marker, although some lineages such as UCS and THCA show a favorable association.

KIRC, UCEC, and ACC are the cancer types where RPL32P33 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	III,IV	0.320	0.521	.001	49	view →
UCEC	DFS	Quartile	All	0.753	0.869	.001	42	view →
ACC	DFS	Quartile	All	0.161	0.528	.003	37	view →
LIHC	DFS	Tertile	All	0.185	0.329	.002	22	view →
UCS	DFS	Median	IV	0.835	0.490	.031	18	view →
THCA	DFS	Tertile	All	0.977	0.741	.007	18	view →
HNSC	DFS	Median	IV	0.702	0.580	.013	16	view →
SARC	DFS	Quartile	All	0.187	0.476	.001	16	view →
READ	DFS	Median	IV	0.399	0.820	.010	12	view →
LAML	DFS	Tertile	All	0.688	0.507	.032	10	view →
PRAD	DFS	Tertile	All	0.882	0.953	.002	10	view →
BRCA	OS	Median	All	0.956	0.967	.031	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RPL32P33–KIRC (DFS)

Open the KIRC breakdown →